Status:

UNKNOWN

Multi Donor Mismatched Stem Cell Transplantation (MDT)

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Graft-Versus-Host Disease

Eligibility:

All Genders

Up to 70 years

Phase:

PHASE1

PHASE2

Brief Summary

The proposed research focuses on the development of innovative protocol of mismatched stem cell transplantation with combined 2 different haplo stem cell transplantation (SCT) donors which are mismatc...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patient age 0-70 years old with leukemia in 1st remission at high risk of relapse because of unfavorable prognostic features, at 2nd CR or MDS without an readily available matched donor (related or unrelated).
  • Patients must have a mismatched donor willing and capable of donating peripheral blood stem cells and/or bone marrow progenitor cells using conventional techniques, and lymphocytes if indicated (mismatched defined as 3/6-4/6 HLA matching).
  • Each patient / patient's guardian must sign written informed consent.
  • Patients must have an ECOG PS ≤ 2; Creatinine \<2.0 mg/dl; Ejection fraction \>40%; DLCO \>50% of predicted; Serum bilirubin \<3 gm/dl; elevated GPT or GOT \<3 x normal values.
  • Exclusion criteria:
  • Not fulfilling any of the inclusion criteria.
  • Not in CR (if the indication for transplant is leukemia).
  • Active life-threatening infection.
  • Overt untreated infection.
  • HIV seropositivity, Hepatitis B or C antigen positivity with evidence of active hepatitis.
  • Pregnant or lactating women.
  • Donor contraindication (HIV seropositive confirmed by Western Blot, Hepatitis B antigenemia, HCV, evidence of bone marrow disease, unable to donate bone marrow or peripheral blood due to concurrent medical condition).
  • Previous autologous or allogeneic stem cell transplantation.
  • Inability to comply with study requirements.

Exclusion

    Key Trial Info

    Start Date :

    July 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 1 2020

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT00716690

    Start Date

    July 1 2008

    End Date

    June 1 2020

    Last Update

    February 19 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hadassah Medical Organization

    Jerusalem, Israel